Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
14.53
+0.68 (4.91%)
At close: Jun 16, 2026
Faeth Therapeutics Employees
Faeth Therapeutics had 29 employees as of December 31, 2025. The number of employees increased by 14 or 93.33% compared to the previous year.
Employees
29
Change (1Y)
14
Growth (1Y)
93.33%
Revenue / Employee
n/a
Profits / Employee
-$6,360,586
Market Cap
19.50M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 29 | 14 | 93.33% | 29 | 0 |
| Dec 31, 2024 | 15 | -13 | -46.43% | 14 | 1 |
| Dec 31, 2023 | 28 | 0 | - | 27 | 1 |
| Dec 31, 2022 | 28 | -28 | -50.00% | 28 | 0 |
| Dec 31, 2021 | 56 | 24 | 75.00% | 56 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Werewolf Therapeutics | 39 |
| Passage Bio | 24 |
| Atossa Therapeutics | 16 |
| Lipocine | 14 |
| NewcelX | 12 |
| Cellectar Biosciences | 11 |
| VYNE Therapeutics | 10 |